Enliven Therapeutics Stock Forward View - Simple Moving Average
| ELVN Stock | 28.01 0.08 0.29% |
Enliven Stock outlook is based on your current time horizon. Although Enliven Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Enliven Therapeutics' systematic risk associated with finding meaningful patterns of Enliven Therapeutics fundamentals over time.
As of today the relative strength index (rsi) of Enliven Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.48) | EPS Estimate Current Year (1.80) | EPS Estimate Next Year (1.98) | Wall Street Target Price 41.375 | EPS Estimate Current Quarter (0.47) |
Using Enliven Therapeutics hype-based prediction, you can estimate the value of Enliven Therapeutics from the perspective of Enliven Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enliven Therapeutics using Enliven Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enliven using crowd psychology based on the activity and movement of Enliven Therapeutics' stock price.
Enliven Therapeutics Implied Volatility | 1.83 |
Enliven Therapeutics' implied volatility exposes the market's sentiment of Enliven Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enliven Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enliven Therapeutics stock will not fluctuate a lot when Enliven Therapeutics' options are near their expiration.
The Simple Moving Average forecasted value of Enliven Therapeutics on the next trading day is expected to be 28.01 with a mean absolute deviation of 0.85 and the sum of the absolute errors of 49.95. Enliven Therapeutics after-hype prediction price | USD 27.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enliven Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Enliven contract
Based on the Rule 16, the options market is currently suggesting that Enliven Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-03-20 option contract. With Enliven Therapeutics trading at USD 28.01, that is roughly USD 0.032 . If you think that the market is fully incorporating Enliven Therapeutics' daily price movement you should consider acquiring Enliven Therapeutics options at the current volatility level of 1.83%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Enliven Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Enliven Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Enliven Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Enliven Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Enliven Therapeutics' open interest, investors have to compare it to Enliven Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Enliven Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Enliven. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Enliven Therapeutics Additional Predictive Modules
Most predictive techniques to examine Enliven price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enliven using various technical indicators. When you analyze Enliven charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Enliven Therapeutics Simple Moving Average Price Forecast For the 14th of February 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Enliven Therapeutics on the next trading day is expected to be 28.01 with a mean absolute deviation of 0.85, mean absolute percentage error of 2.50, and the sum of the absolute errors of 49.95.Please note that although there have been many attempts to predict Enliven Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enliven Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Enliven Therapeutics Stock Forecast Pattern
| Backtest Enliven Therapeutics | Enliven Therapeutics Price Prediction | Research Analysis |
Enliven Therapeutics Forecasted Value
In the context of forecasting Enliven Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enliven Therapeutics' downside and upside margins for the forecasting period are 20.36 and 35.66, respectively. We have considered Enliven Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Enliven Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Enliven Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.3529 |
| Bias | Arithmetic mean of the errors | -0.1563 |
| MAD | Mean absolute deviation | 0.8466 |
| MAPE | Mean absolute percentage error | 0.0385 |
| SAE | Sum of the absolute errors | 49.95 |
Predictive Modules for Enliven Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enliven Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enliven Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enliven Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Enliven Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enliven Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enliven Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enliven Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Enliven Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enliven Therapeutics' historical news coverage. Enliven Therapeutics' after-hype downside and upside margins for the prediction period are 19.88 and 35.18, respectively. We have considered Enliven Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enliven Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Enliven Therapeutics is based on 3 months time horizon.
Enliven Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Enliven Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enliven Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enliven Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.66 | 7.65 | 0.48 | 2.51 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
28.01 | 27.53 | 1.71 |
|
Enliven Therapeutics Hype Timeline
Enliven Therapeutics is currently traded for 28.01. The entity has historical hype elasticity of -0.48, and average elasticity to hype of competition of -2.51. Enliven is anticipated to decline in value after the next headline, with the price expected to drop to 27.53. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.71%, whereas the daily expected return is currently at 0.66%. The volatility of related hype on Enliven Therapeutics is about 201.02%, with the expected price after the next announcement by competition of 25.50. About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Enliven Therapeutics was currently reported as 8.03. The company recorded a loss per share of 1.81. Enliven Therapeutics had not issued any dividends in recent years. The entity had 1:4 split on the 24th of February 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Enliven Therapeutics to cross-verify your projections.Enliven Therapeutics Related Hype Analysis
Having access to credible news sources related to Enliven Therapeutics' direct competition is more important than ever and may enhance your ability to predict Enliven Therapeutics' future price movements. Getting to know how Enliven Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enliven Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| COR | Cencora | (15.03) | 8 per month | 0.00 | (0.05) | 1.93 | (2.62) | 10.81 | |
| REGN | Regeneron Pharmaceuticals | (9.94) | 9 per month | 1.45 | 0.11 | 3.40 | (3.11) | 8.86 | |
| IDXX | IDEXX Laboratories | (3.03) | 10 per month | 0.00 | (0.15) | 3.61 | (3.18) | 9.91 | |
| HLN | Haleon plc | 0.06 | 8 per month | 0.96 | 0.14 | 2.81 | (1.81) | 6.06 | |
| CI | Cigna Corp | 7.33 | 7 per month | 1.26 | 0.04 | 3.15 | (2.38) | 7.49 | |
| ELV | Elevance Health | (0.86) | 7 per month | 2.91 | 0.02 | 3.78 | (2.54) | 19.95 | |
| BDX | Becton Dickinson and | (0.86) | 8 per month | 0.64 | 0.19 | 4.06 | (1.77) | 7.13 | |
| ARGX | argenx NV ADR | (13.21) | 9 per month | 0.00 | (0.07) | 2.29 | (3.07) | 7.34 | |
| TAK | Takeda Pharmaceutical Co | 1.29 | 13 per month | 0.00 | 0.33 | 2.49 | (1.05) | 4.49 |
Other Forecasting Options for Enliven Therapeutics
For every potential investor in Enliven, whether a beginner or expert, Enliven Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enliven Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enliven. Basic forecasting techniques help filter out the noise by identifying Enliven Therapeutics' price trends.Enliven Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enliven Therapeutics stock to make a market-neutral strategy. Peer analysis of Enliven Therapeutics could also be used in its relative valuation, which is a method of valuing Enliven Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enliven Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Enliven Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enliven Therapeutics shares will generate the highest return on investment. By undertsting and applying Enliven Therapeutics stock market strength indicators, traders can identify Enliven Therapeutics entry and exit signals to maximize returns.
Enliven Therapeutics Risk Indicators
The analysis of Enliven Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enliven Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enliven stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.91 | |||
| Semi Deviation | 3.67 | |||
| Standard Deviation | 7.44 | |||
| Variance | 55.34 | |||
| Downside Variance | 17.8 | |||
| Semi Variance | 13.48 | |||
| Expected Short fall | (4.48) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Enliven Therapeutics
The number of cover stories for Enliven Therapeutics depends on current market conditions and Enliven Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enliven Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enliven Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enliven Therapeutics Short Properties
Enliven Therapeutics' future price predictability will typically decrease when Enliven Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enliven Therapeutics often depends not only on the future outlook of the potential Enliven Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enliven Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.1 M | |
| Cash And Short Term Investments | 313.4 M |
Check out Historical Fundamental Analysis of Enliven Therapeutics to cross-verify your projections. To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Pharmaceuticals sector continue expanding? Could Enliven diversify its offerings? Factors like these will boost the valuation of Enliven Therapeutics. Projected growth potential of Enliven fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Enliven Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Enliven Therapeutics requires distinguishing between market price and book value, where the latter reflects Enliven's accounting equity. The concept of intrinsic value - what Enliven Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Enliven Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Enliven Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enliven Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enliven Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.